Arranta Bio's Aaron B. Cowley, Ph.D., Melanie Cerullo and Jeff Heiser explain the challenges in CMC development for live biotherapeutic products targeting the microbiome and how the company is helping to establish a standardized framework for the industry.
.svg)
